5 Followers on Owler
Myotherix focuses on developing therapies for patients suffering from Duchenne muscular dystrophy and muscle disorders... Read more
OverviewFundingNews & Insights
Myotherix focuses on developing therapies for patients suffering from Duchenne muscular dystrophy and muscle disorders... Read more
Myotherix, Inc. President & CEO: Michael G. Kelly

President & CEO

Michael G. Kelly

CEO Approval Rating

70/100

2013

Private

Add Industry
Add Sector

Est. Annual Revenue
<$1M
Agree?
Est. Employees
<10
Agree?
Funding
$8.4M

Trending Companies